| Prev Close | 6.68 |
| Day Low/High | 6.31 / 6.95 |
| 52 Wk Low/High | 2.10 / 8.81 |
| Avg Volume | 1.01M |
Ardelyx Inc. (ARDX)
6.92
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 85.81M |
| Market Cap | 573.19M |
| EPS | -1.60 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Abeona Shares Higher After Pricing Stock Offering -- Biotech Movers
The clinical-stage biopharmaceutical firm said Oct. 16 it has priced an underwritten public offering of five million shares at $16 apiece.
This Market Action Is Not Creating Many Setups
Until market conditions shift, I won't be making any sizable buys.
Ardelyx Soars on Positive Phase 3 Data -- Biotech Movers
The Fremont, Calif.-based firm has unveiled positive results from its second Phase 3 study of tenapanor for irritable bowel syndrome with constipation.
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Following Galenica's $1.5 billion bid for Relypsa, investors are beginning to search for the next target.
Ardelyx Has Big Potential
This small-cap company's shares are half where they ended 2015.
Profiting on Small-Cap Biotech Earnings
Don't trade the headline numbers, but cash in on those traders that do.
